Bosacki Steven 4
4 · BioPharmX Corp · Filed Jul 18, 2019
Insider Transaction Report
Form 4
BioPharmX CorpBPMX
Bosacki Steven
Chief Operating Officer
Transactions
- Award
Option to purchase common stock
2019-07-16$0.44/sh+91,000$40,040→ 91,000 totalExercise: $0.44From: 2019-08-31Exp: 2029-07-16→ Common stock (91,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable ratably over 36 months